PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
نویسندگان
چکیده
منابع مشابه
Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.
A few observations and much reasoning leads to error; many observations and a little reasoning to truth.-Alexis Carrell oncerns have been raised about safety of calcium channel blockers in patients with heart failure since their introduction into cardiovascular medicine more than 25 years ago. By inhibiting the influx of calcium into myocardial cells, calcium channel-blocking drugs can depress ...
متن کاملStem cell therapy for chronic heart failure.
PURPOSE OF REVIEW The aim of this review was to discuss recent advances in clinical aspects of stem cell therapy in heart failure with emphasis on patient selection, stem cell types and delivery methods. RECENT FINDINGS Several stem cell types have been considered for the treatment of patients with heart failure. In nonischemic heart failure, transplantation of CD34 cells improved myocardial ...
متن کاملCardiac resynchronization therapy in chronic heart failure.
Cardiac resynchronisation therapy (CRT) has emerged as a treatment option for patients with severe, drug-refractory heart failure and signs of intraventricular dyssynchrony. In clinical trials CRT reduced the overall mortality, improved symptoms, exercise tolerance, and left ventricular function, as compared with optimised medical therapy alone. One of the challenging fields in patient selectio...
متن کاملEDITORIAL / - Blockade - rational or irrational therapy for congestive heart failure ?
CLINICAL AND BASIC RESEARCH in the arena of congestive heart failure is intensive. Nevertheless, accepted treatment modalities for patients with this debilitating and fatal disease are limited to just three: digitalis, diuretics, and vasodilators, and only the latter has been demonstrated to improve survival in patients with congestive heart failure.1 Although cardiac transplantation markedly r...
متن کاملStem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
Aim of the Review The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods. Recent Findings Several stem cell types have been considered for the treatment of DCMP patients. Bone marrow-derived cells and CD34+ cells have been demonstrated to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rational Pharmacotherapy in Cardiology
سال: 2017
ISSN: 2225-3653,1819-6446
DOI: 10.20996/1819-6446-2017-13-4-482-488